We are live on ! Find out more
VCG

Vantage Consulting Group Portfolio holdings

AUM $19.7M
1-Year Est. Return 280.87%
This Fund
S&P 500
This Quarter Est. Return
-4.67%
1 Year Est. Return
+280.87%
3 Year Est. Return
+261.08%
5 Year Est. Return
+180.34%
10 Year Est. Return
–
AUM
$256M
AUM Growth
-$116M
Cap. Flow
-$98.8M
Cap. Flow %
-38.55%
Top 10 Hldgs %
75.13%
Holding
237
New
6
Increased
88
Reduced
120
Closed
22

Top Buys

Rank Stock Value
1
CEG icon
Constellation Energy
CEG
+$362K
2
MOH icon
Molina Healthcare
MOH
+$256K
3
BBWI icon
Bath & Body Works
BBWI
+$180K
4
AAL icon
American Airlines Group
AAL
+$177K
5
PVH icon
PVH
PVH
+$164K

Top Sells

Rank Stock Value
1
RPRX icon
Royalty Pharma
RPRX
+$73.6M
2
ITCI
Intra-Cellular Therapies Inc.
ITCI
+$11.9M
3
SSPY icon
Syntax Stratified LargeCap ETF
SSPY
+$4.17M
4
SMDY
Syntax Stratified MidCap ETF
SMDY
+$420K
5
CVX icon
Chevron
CVX
+$389K

Sector Composition

Rank Sector Weight
1 Healthcare 57.28%
2 Technology 5.13%
3 Consumer Staples 4.53%
4 Consumer Discretionary 3.87%
5 Energy 2.14%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow
PEP icon
226
PepsiCo
PEP
$190B
– –
-1,226
Closed -$213K
PNR icon
227
Pentair
PNR
$10.4B
– –
-2,752
Closed -$201K
ROL icon
228
Rollins
ROL
$18.3B
– –
-6,491
Closed -$222K
RSG icon
229
Republic Services
RSG
$64.8B
– –
-1,530
Closed -$213K
SNA icon
230
Snap-on
SNA
$21.2B
– –
-953
Closed -$205K
SWK icon
231
Stanley Black & Decker
SWK
$14.3B
– –
-1,063
Closed -$201K
WM icon
232
Waste Management
WM
$90.6B
– –
-1,257
Closed -$210K
XYL icon
233
Xylem
XYL
$27.3B
– –
-1,684
Closed -$202K
GAP
234
The Gap Inc
GAP
$7.23B
– –
-16,287
Closed -$287K
ITCI
235
DELISTED
Intra-Cellular Therapies Inc.
ITCI
– –
-226,670
Closed -$11.9M
SPPI
236
DELISTED
Spectrum Pharmaceuticals Inc
SPPI
– –
-29,181
Closed -$37K
PBCT
237
DELISTED
People's United Financial Inc
PBCT
– –
-10,428
Closed -$186K
6 7 8 9
10

Similar funds

MVG
Madrona Venture Group Seattle, Washington $22.1M AUM 86.9% 1-Year Est. Return
NCM
Northwest Capital Management Lake Oswego, Oregon $23.1M AUM 13.6% 1-Year Est. Return
FFGIM
Founders Fund Growth II Management San Francisco, California $23.7M AUM
PIM
Profit Investment Management North Bethesda, Maryland $24.7M AUM 21.29% 1-Year Est. Return
HFG
Harborfront Financial Group Ludington, Michigan $13.4M AUM
SWM
Stark Wealth Management Bethlehem, Pennsylvania $26.6M AUM 23.19% 1-Year Est. Return
ICM
Infini Capital Management Central, Hong Kong $12.4M AUM 53.5% 1-Year Est. Return
SM
Southport Management Wilson, Wyoming $28.6M AUM 41.61% 1-Year Est. Return

Vantage Consulting Group's Q1 2022 Portfolio in Review

As of Q1 2022, Vantage Consulting Group held 237 positions worth $256M, down 31% from $372M the previous quarter. Its ten largest holdings account for 75% of the portfolio.

Vantage Consulting Group withdrew a net $98.8M in Q1 2022, closing 22 positions and reducing 120 holdings. Its most notable exit was Intra-Cellular Therapies Inc., an estimated $11.9M position sold in full.

By sector, the portfolio is most concentrated in Healthcare at 57% of assets, down from 67% a quarter earlier, followed by Technology and Consumer Staples.

Against the trend, Vantage Consulting Group opened a new position in Constellation Energy worth $417K.

  • Vantage Consulting Group's largest Q1 2022 buy was Constellation Energy: 7,415 shares worth $417K.
  • Vantage Consulting Group added most to Bath & Body Works in Q1 2022, an estimated $180K increase.
  • Vantage Consulting Group's biggest Q1 2022 reduction was Royalty Pharma, cutting an estimated $73.6M.
  • Vantage Consulting Group fully exited Intra-Cellular Therapies Inc. in Q1 2022, selling an estimated $11.9M.
  • Vantage Consulting Group's ten largest holdings make up 75% of its $256M portfolio in Q1 2022.
  • Vantage Consulting Group opened 6 new positions and closed 22 in Q1 2022.
  • Vantage Consulting Group's portfolio value fell 31% quarter-over-quarter to $256M.

Based on Vantage Consulting Group's 13F filing for Q1 2022, filed 16 May 2022.